Reversion of multidrug resistance in human glioma by RNA interference (Q39958316)

15 September 2017

title

Reversion of multidrug resistance in human glioma by RNA interference (English)

1 reference

15 September 2017

main subject

multiple drug resistance

1 reference

1 reference

Peng Zhao

1

1 reference

15 September 2017

Yazhuo Zhang

series ordinal

2

1 reference

15 September 2017

Meizhen Sun

series ordinal

3

1 reference

15 September 2017

Yue He

series ordinal

4

1 reference

15 September 2017

publication date

1 July 2008

1 reference

15 September 2017

published in

Neurological Research

1 reference

15 September 2017

volume

30

1 reference

15 September 2017

issue

6

1 reference

15 September 2017

page(s)

562-566

1 reference

Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

Multidrug resistance in glioblastoma. Chemosensitivity testing and immunohistochemical demonstration of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

Modulation of multidrug resistance gene (mdr-1) with antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

RNA interference. The short answer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

A system for stable expression of short interfering RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

Revealing the world of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

Molecular medicine for the brain: silencing of disease genes with RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

Establishment of conditional vectors for hairpin siRNA knockdowns

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

Retrovirus-delivered siRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

Pharmacogenomics of ABC transporters and its role in cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

Transport of phosphatidylserine via MDR1 (multidrug resistance 1)P-glycoprotein in a human gastric carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

P-glycoprotein (ABCB1) but not multidrug resistance-associated protein 1 (ABCC1) is induced by doxorubicin in primary cultures of rat astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F174313208X297869

21 January 2018

Identifiers

DOI

10.1179/174313208X297869

1 reference

15 September 2017

1 reference